Onyx to provide specialist separation services
Onyx Scientific is planning to broaden its offering to the global pharmaceutical and biotech industries.
The contract manufacturing organisation (CMO) has struck-up a strategic alliance with UK-based Reach Separations, which will allow it to deliver more specialist purification and separation services to bolster its early stage development services.
As part of the deal, Onyx Scientific will be now able to offer custom separation for companies in drug discovery and intermediate environments.
This includes chiral, reverse phase and normal phase chromatography using Supercritical Fluid Chromatography (SFC) and High Performance Liquid Chromatography (HPLC). With MHRA and FDA licensed facilities in the UK and India,
Onyx Scientific supports pharmaceutical and biotech companies from medicinal chemistry and preclinical through Phase I-III, scaling-up to large scale commercial API production.
Reach Separations is located in BioCity in Nottingham, which is one of Europe’s largest bioscience incubators that currently hosts over 70 companies and has a rich heritage in drug discovery.
The Biotage Isolera flash range is designed to help purify synthesis reaction mixtures and mixes of organic compounds.
Dr Frank David at the Research Institute of Chromatography describes how they are using Agilent’s automated systems to improve sample preparation.
Showcasing at ASMS, the HILIC technology highlights LC-MS separation of polar compounds.
The 21CFR part 11 module for software control claims to accelerate adoption of micro LC technology.
The software can be used with the ChemStation OpenLAB chromatography data system.